Selecta Biosciences Inc
NASDAQ:SELB
Selecta Biosciences Inc
NASDAQ:SELB
Price:
0.7465 USD
5.14%
Market Closed
Updated:
May 29, 2024
Selecta Biosciences Inc
Net Issuance of Debt
|
Selecta Biosciences Inc
Net Issuance of Debt Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Selecta Biosciences Inc
NASDAQ:SELB
|
Net Issuance of Debt
-$2.6m
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Debt
$12.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
181%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Debt
$2.6B
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Debt
-$45.7m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
4%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Selecta Biosciences Inc's Net Issuance of Debt?
Net Issuance of Debt
-2.6m
USD
-2.6m
USD
Based on the financial report for Jun 30, 2023, Selecta Biosciences Inc's Net Issuance of Debt amounts to -2.6m USD.
What is Selecta Biosciences Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 3Y
28%
28%
The average annual Net Issuance of Debt growth rates for Selecta Biosciences Inc have been 28% over the past three years .
You don't have any saved screeners yet
